Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-19

Clinical Trial Update: A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne [Phase 2]

View source ↗

Summary

Phase 2 trial update for NVN1000 Gel in acne vulgaris completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NVN1000 Gel (NVN1000)

Snippet

Sponsor: Novan, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED